IMR Press / CEOG / Volume 26 / Issue 1 / pii/1999005

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

New technique for artificial lung maturation Direct intramuscular fetal corticosteroid therapy

Show Less
1 Institute of Obstetrics and Gynecology, Clinical Center of Serbia, Belgrade, Yugoslavia
Clin. Exp. Obstet. Gynecol. 1999, 26(1), 16–19;
Published: 10 March 1999
Abstract

The aim of this study was to present a new technique of administration of antenatal corticosteroid therapy in order to cause fetal lung maturation. A single dexamethasone dose of 4 mg was applied directly to the fetal gluteal musculature by ultrasound-guided intramuscular injection 48 h before delivery. This technique of fetal corticosteroid therapy was applied in six cases. Our patients had high risk pre­gnancies (preeclampsia diabetes mellitus, intracranial hemorrhage, epilepsy, hyperthyreosis). The pregnancies were terminated in the mother’s vital interest. The lecithin/sphyngomyelin (US) ratio was <1.5: 1. There were no procedure-related complications. The fetuses were delivered by cesarean, 48 hours later except for the vaginal delivery in the patient in which fetal death occurred in utero. In five cases an uneventful outcome of fetuses indicated that direct fetal corticosteroid treatment improved postnatal lung function in preterm fetuses. A new technique of corticosteroid application successfully prevents respiratory distress in preterm infants decreasing the risk of maternal complications. To our knowledge, this is the first report of fetal intramuscular corticosteroid therapy in the human population.

Keywords
Respiratory distress syndrome
Corticosteroid
Fetal intramuscular therapy
Lung maturation
Share
Back to top